Calpain-overexpressing mouse models have demonstrated cardiac enlargement and fibrosis, notably, in Tg-Capn2/tTA mice that develop DCM with chamber enlargement, myocardial fibrosis, and functional decline by 8 months of age [11]. Here, CAPN2 is linked to Myocardial fibrosis.